Literature DB >> 31690638

Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.

Claudia Manca1,2,3, Besma Boubertakh1,2,3, Nadine Leblanc1,3,4, Thomas Deschênes3,4,5, Sebastien Lacroix1,3,4, Cyril Martin1,3, Alain Houde3,4, Alain Veilleux3,4,5, Nicolas Flamand1,2,3, Giulio G Muccioli6, Frédéric Raymond3,4,5, Patrice D Cani6,7, Vincenzo Di Marzo1,2,3,4,5, Cristoforo Silvestri8,2,3.   

Abstract

The gut microbiota is a unique ecosystem of microorganisms interacting with the host through several biochemical mechanisms. The endocannabinoidome (eCBome), a complex signaling system including the endocannabinoid system, approximately 50 receptors and metabolic enzymes, and more than 20 lipid mediators with important physiopathologic functions, modulates gastrointestinal tract function and may mediate host cell-microbe communications there. Germ-free (GF) mice, which lack an intestinal microbiome and so differ drastically from conventionally raised (CR) mice, offer a unique opportunity to explore the eCBome in a microbe-free model and in the presence of a reintroduced functional gut microbiome through fecal microbiota transplant (FMT). We aimed to gain direct evidence for a link between the microbiome and eCBome systems by investigating eCBome alterations in the gut in GF mice before and after FMT. Basal eCBome gene expression and lipid profiles were measured in various segments of the intestine of GF and CR mice at juvenile and adult ages using targeted quantitative PCR transcriptomics and LC-MS/MS lipidomics. GF mice exhibited age-dependent modifications in intestinal eCBome gene expression and lipid mediator levels. FMT from CR donor mice to age-matched GF male mice reversed several of these alterations, particularly in the ileum and jejunum, after only 1 week, demonstrating that the gut microbiome directly impacts the host eCBome and providing a cause-effect relationship between the presence or absence of intestinal microbes and eCBome signaling. These results open the way to new studies investigating the mechanisms through which intestinal microorganisms exploit eCBome signaling to exert some of their physiopathologic functions.
Copyright © 2020 Manca et al.

Entities:  

Keywords:  endocannabinoids; fecal microbiota transplant; gene expression; germ-free phenotype; gut microbiome; intestine; lipidomics.

Year:  2019        PMID: 31690638      PMCID: PMC6939599          DOI: 10.1194/jlr.RA119000424

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  84 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Interactions between commensal intestinal bacteria and the immune system.

Authors:  Andrew J Macpherson; Nicola L Harris
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

4.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

5.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties.

Authors:  Michiel G J Balvers; Kitty C M Verhoeckx; Pierluigi Plastina; Heleen M Wortelboer; Jocelijn Meijerink; Renger F Witkamp
Journal:  Biochim Biophys Acta       Date:  2010-06-27

7.  Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).

Authors:  Dina Navia-Paldanius; Juha R Savinainen; Jarmo T Laitinen
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

Review 8.  Role of the normal gut microbiota.

Authors:  Sai Manasa Jandhyala; Rupjyoti Talukdar; Chivkula Subramanyam; Harish Vuyyuru; Mitnala Sasikala; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

9.  Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis.

Authors:  Cristina Hernández-Chirlaque; Carlos J Aranda; Borja Ocón; Fermín Capitán-Cañadas; Mercedes Ortega-González; Juan Jesús Carrero; María Dolores Suárez; Antonio Zarzuelo; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  J Crohns Colitis       Date:  2016-04-26       Impact factor: 9.071

10.  GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Authors:  Lina M Lauffer; Roman Iakoubov; Patricia L Brubaker
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more
  26 in total

1.  Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens.

Authors:  Melissa Ellermann; Alline R Pacheco; Angel G Jimenez; Regan M Russell; Santiago Cuesta; Aman Kumar; Wenhan Zhu; Gonçalo Vale; Sarah A Martin; Prithvi Raj; Jeffrey G McDonald; Sebastian E Winter; Vanessa Sperandio
Journal:  Cell       Date:  2020-10-07       Impact factor: 41.582

Review 2.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

3.  Remodeling of the Dermal Extracellular Matrix in a Tissue-Engineered Psoriatic Skin Model by n-3 Polyunsaturated Fatty Acids.

Authors:  Mélissa Simard; Alexe Grenier; Geneviève Rioux; Andréa Tremblay; Isalie Blais; Nicolas Flamand; Roxane Pouliot
Journal:  Biomedicines       Date:  2022-05-06

Review 4.  The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders.

Authors:  Roberto Coccurello; Maria Cristina Marrone; Mauro Maccarrone
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

5.  Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism.

Authors:  Charlotte Lefort; Martin Roumain; Matthias Van Hul; Marialetizia Rastelli; Rita Manco; Isabelle Leclercq; Nathalie M Delzenne; Vincenzo Di Marzo; Nicolas Flamand; Serge Luquet; Cristoforo Silvestri; Giulio G Muccioli; Patrice D Cani
Journal:  Cells       Date:  2020-05-18       Impact factor: 6.600

6.  The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
.

Authors:  Vincenzo Di Marzo
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

7.  Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota.

Authors:  Niokhor Dione; Sébastien Lacroix; Ulrike Taschler; Thomas Deschênes; Armita Abolghasemi; Nadine Leblanc; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  Cells       Date:  2020-12-17       Impact factor: 6.600

Review 8.  Cannabidiol and Neurodevelopmental Disorders in Children.

Authors:  Keith A Kwan Cheung; Murray D Mitchell; Helen S Heussler
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

Review 9.  Role of the Endocannabinoid System in the Adipose Tissue with Focus on Energy Metabolism.

Authors:  Volatiana Rakotoarivelo; Jyoti Sihag; Nicolas Flamand
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

10.  Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.

Authors:  Sophie Castonguay-Paradis; Sébastien Lacroix; Gabrielle Rochefort; Lydiane Parent; Julie Perron; Cyril Martin; Benoît Lamarche; Frédéric Raymond; Nicolas Flamand; Vincenzo Di Marzo; Alain Veilleux
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.